Soluble melanoma cell adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells through angiomotin.
about
Endothelial Progenitor Cells Physiology and Metabolic Plasticity in Brain Angiogenesis and Blood-Brain Barrier ModelingEndothelial cell adhesion molecule CD146: implications for its role in the pathogenesis of COPDSequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma.Dendritic Versus Tumor Cell Presentation of Autologous Tumor Antigens for Active Specific Immunotherapy in Metastatic Melanoma: Impact on Long-Term Survival by Extent of Disease at the Time of Treatment.Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient-derived xenografts.Lovastatin Reduces Stemness via Epigenetic Reprograming of BMP2 and GATA2 in Human Endometrium and Endometriosis.Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer.Why is melanoma so metastatic?Genetics of breast cancer bone metastasis: a sequential multistep pattern.Expression of pro-angiogenic genes in mesenchymal stem cells derived from dermis of patients with psoriasis.The multifaceted role of CD146/MCAM in the promotion of melanoma progression.Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146.Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors.The physiological role of Motin family and its dysregulation in tumorigenesis.Soluble CD146 boosts therapeutic effect of endothelial progenitors through proteolytic processing of short CD146 isoform.Early prediction of revascularisation by angiomotin-targeting positron emission tomography
P2860
Q28072654-7B280AE0-9DC1-47E2-B4D9-0CBD20A04F32Q28573590-46B9C6D5-6BE6-445D-9C26-8D17C61A04A6Q33935453-D440863E-0033-402E-B605-4C16F07B9A2DQ35821826-136856BE-9B79-49AD-8044-60771217018AQ36264686-0CE729AA-F3F6-4F37-890A-C98373AEFE80Q37590926-AD99B9C3-2238-4B9E-85F6-2EF3722EBED7Q37632126-A672209D-6777-4208-A4E3-956C7FB9CDDEQ38150869-C176DE47-0634-4128-911B-EEA237FEF447Q38184928-F1A1B335-0E39-48BD-AF21-A056F5E75D32Q38922644-1001C7DE-27C4-4CC2-97C6-38AF48E351B0Q39038566-7F004A9E-3E93-447E-A1D4-800AF143EF46Q39172101-5B95E4C6-C2D5-48A2-8B21-F4AA7712E5AAQ40534218-2A8A352A-87E8-4402-9955-A159A4CC9856Q52591394-C54CEE6D-7ACE-4C1A-AABF-3317E9BD0631Q52870031-C5A9B87F-16F4-47A4-AAD7-4081FD79E1AAQ59138135-9CA1A69B-B691-4D3D-AF7E-423EA4BEEB57
P2860
Soluble melanoma cell adhesion molecule (sMCAM/sCD146) promotes angiogenic effects on endothelial progenitor cells through angiomotin.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Soluble melanoma cell adhesion ...... itor cells through angiomotin.
@ast
Soluble melanoma cell adhesion ...... itor cells through angiomotin.
@en
Soluble melanoma cell adhesion molecule
@nl
type
label
Soluble melanoma cell adhesion ...... itor cells through angiomotin.
@ast
Soluble melanoma cell adhesion ...... itor cells through angiomotin.
@en
Soluble melanoma cell adhesion molecule
@nl
prefLabel
Soluble melanoma cell adhesion ...... itor cells through angiomotin.
@ast
Soluble melanoma cell adhesion ...... itor cells through angiomotin.
@en
Soluble melanoma cell adhesion molecule
@nl
P2093
P2860
P356
P1476
Soluble melanoma cell adhesion ...... itor cells through angiomotin.
@en
P2093
Alexandrine Foucault-Bertaud
Caroline Subrini
Daniel Lafitte
Elise Kaspi
Florence Sabatier
Françoise Dignat-George
Jean-Claude Lissitzky
Jimmy Stalin
Karim Harhouri
Lars Holmgren
P2860
P304
P356
10.1074/JBC.M112.446518
P407
P577
2013-02-06T00:00:00Z